Market News Video
MNV MNV 10 Stocks Crossing Below Book Value
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Analysts Expect PJP To Hit $72
Thursday, February 8, 9:20 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

CORT Crosses Below Key Moving Average Level
Thursday, February 8, 12:13 PM ET, by Market News Video Staff

In trading on Thursday, shares of Corcept Therapeutics Inc (CORT) crossed below their 200 day ...

Novartis Breaks Below 200-Day Moving Average - Notable for NVS
Thursday, February 8, 4:16 PM ET, by Market News Video Staff

In trading on Thursday, shares of Novartis (NVS) crossed below their 200 day moving average ...

Corcept Therapeutics Becomes Oversold (CORT)
Thursday, February 8, 4:43 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

VEA, NSRGY, NVS, TM: ETF Inflow Alert
Thursday, February 15, 10:52 AM ET, by Market News Video Staff

Symbols mentioned in this story: VEA, NSRGY, NVS, TM Exchange traded funds (ETFs) trade just ...

NVS Makes Bearish Cross Below Critical Moving Average

By Market News Video Staff, Wednesday, January 4, 12:06 PM ET
Play Video: Learn About The 200 DMA

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

In trading on Wednesday, shares of Novartis (NYSE:NVS) crossed below their 200 day moving average of $57.64, changing hands as low as $57.48 per share. Novartis shares are currently trading down about 1% on the day. The chart below shows the one year performance of NVS shares, versus its 200 day moving average:

Novartis 200 Day Moving Average Chart

Looking at the chart above, NVS's low point in its 52 week range is $51.60 per share, with $64.82 as the 52 week high point that compares with a last trade of $57.59.

NVS makes up 5.56% of the Market 2000+ HOLDRS ETF (MKH)

NVS operates in the Drugs & Pharmaceuticals sector, among companies like DepoMed, Inc. (NASDAQ:DEPO) which is off about 1.3% today, and Corcept Therapeutics Inc (NASDAQ:CORT) trading lower by about 1.4%. Below is a three month price history chart comparing the stock performance of NVS, versus DEPO and CORT.

NVS,DEPO,CORT Relative Performance Chart

Special Offer: Join the income investing conversation on with a special Seven Days for Seven Dollars invitation from Forbes

This Article's Word Cloud:   Average   Below   CORT   Corcept   Crossing   DEPO   Days   DepoMed   Dollars   Drugs   Forbes   Join   Looking   Market   Moving   NYSE   Novartis   Offer   Pharmaceuticals   Seven   Special   Start   Stocks   Their   Therapeutics   ValueForum   Wednesday   about   above   among   average   below   changing   chart   companies   compares   comparing   conversation   crossed   currently   down   moving   performance   point   share   shares   trading   versus   week   with
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV MNV Portfolio Channel Stock Market Definitions

NVS Makes Bearish Cross Below Critical Moving Average | Market News Video | Copyright © 2008 - 2018, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.